Current Gene Therapy
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Aims and Scope
Current Gene Therapy is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Liang Cheng (Harbin Medical University Harbin, China). The focus of this journal is pre-clinical or clinical research on gene therapy. Formats of publication include original research reports, review papers, and rapid communications ("letters"). Less
Key Metrics
Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
- PublisherBENTHAM SCIENCE PUBL LTD
- LanguageEnglish
- FrequencyBi-monthly
- LanguageEnglish
- FrequencyBi-monthly
- Publication Start Year2000
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Current Gene Therapy been publishing? 
The Current Gene Therapy has been publishing since 2000 till date.
How frequently is the Current Gene Therapy published?
Current Gene Therapy is published Bi-monthly.
Who is the publisher of Current Gene Therapy?
The publisher of Current Gene Therapy is BENTHAM SCIENCE PUBL LTD.
Where can I find a journal's aims and scope of Current Gene Therapy?
For the Current Gene Therapy's Aims and Scope, please refer to the section above on the page.
How can I view the journal metrics of Current Gene Therapy on editage?
For the Current Gene Therapy metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Current Gene Therapy?
The eISSN number is 1875-5631 and pISSN number is 1566-5232 for Current Gene Therapy.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Progeria, Central nervous system, Ovarian cancer, Anticarsia gemmatalis, RNA editing, Nuclear structure, Serotype, Human cancer, Alzheimer's disease, Glaucoma, Empagliflozin, Machine learning, Plasmid dna, Glioblastoma, Granulocyte, Rna targeting, Weight, Interferon, Gene expression, Esophageal squamous cell carcinoma.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.